[14]Subsite preferences of retroviral proteinases

[1]  I. Thompson.  Visual cortex: Stars and stripes present the colours , 1985, Nature.

[2]  B. Dunn,et al.  Design, synthesis and analysis of new synthetic substrates for the aspartic proteinases. , 1985, Biochemical Society transactions.

[3]  T. Miyata,et al.  Retroviral protease-like sequence in the yeast transposon Ty 1 , 1985, Nature.

[4]  William R. Taylor,et al.  A structural model for the retroviral proteases , 1987, Nature.

[5]  A. Skalka,et al.  Activity of avian retroviral protease expressed in Escherichia coli , 1988, Journal of virology.

[6]  C. Debouck,et al.  Recombinant HIV-1 reverse transcriptase: purification, primary structure, and polymerase/ribonuclease H activities. , 1989, Archives of biochemistry and biophysics.

[7]  A. Skalka,et al.  Avian retroviral protease and cellular aspartic proteases are distinguished by activities on peptide substrates. , 1989, The Journal of biological chemistry.

[8]  A Wlodawer,et al.  Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution. , 1989, Science.

[9]  M. Jaskólski,et al.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. , 1989, Science.

[10]  Maria Miller,et al.  Crystal structure of a retroviral protease proves relationship to aspartic protease family , 1989, Nature.

[11]  B. Dunn,et al.  Hydrolysis of a series of synthetic peptide substrates by the human rhinovirus 14 3C proteinase, cloned and expressed in Escherichia coli. , 1989, The Journal of general virology.

[12]  M. Navia,et al.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 , 1989, Nature.

[13]  Brian W. Metcalf,et al.  Human immunodeficiency virus protease: A target for aids therapy , 1990 .

[14]  Dependence of the P2-S2 stereochemical selectivity of papain on the nature of the catalytic-site chemistry. Quantification of selectivity in the catalysed hydrolysis of the enantiomeric N-acetylphenylalanylglycine 4-nitroanilides. , 1990, The Biochemical journal.

[15]  B. Dunn,et al.  Viral proteinases: weakness in strength. , 1990, Biochimica et biophysica acta.

[16]  V. Kostka,et al.  Sub‐site preferences of the aspartic proteinase from the human immunodeficiency virus, HIV‐1 , 1990, FEBS letters.

[17]  C. Vlahos,et al.  Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease. , 1990, Biochemical and biophysical research communications.

[18]  I. Pastan,et al.  Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates , 1990, Journal of virology.

[19]  I. Weber,et al.  Comparison of inhibitor binding in HIV‐1 protease and in non‐viral aspartic proteases: the role of the flap , 1990, FEBS letters.

[20]  M. Jaskólski,et al.  Structure of the aspartic protease from Rous sarcoma retrovirus refined at 2-A resolution. , 1989, Biochemistry.

[21]  D. Norbeck,et al.  Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. , 1990, Science.

[22]  R. Dixon,et al.  Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution. , 1991, The Journal of biological chemistry.

[23]  W. Farmerie,et al.  Sensitive, soluble chromogenic substrates for HIV-1 proteinase. , 1990, The Journal of biological chemistry.

[24]  V. Kostka,et al.  Hydrolysis of synthetic chromogenic substrates by HIV-1 and HIV-2 proteinases. , 1990, Biochemical and biophysical research communications.

[25]  D. Norbeck,et al.  Chapter 15. HIV Protease Inhibitors , 1991 .

[26]  M. Minnich,et al.  Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease. , 1991, Biochemistry.

[27]  A. Billich,et al.  Analysis of subsite preferences of HIV-1 proteinase using MA/CA junction peptides substituted at the P3-P1' positions. , 1991, Archives of biochemistry and biophysics.

[28]  T. Copeland,et al.  Comparison of the HIV‐1 and HIV‐2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag‐Pol polyproteins , 1991, FEBS letters.

[29]  P. Berti,et al.  Cooperativity of papain-substrate interaction energies in the S2 to S2' subsites. , 1991, Biochemistry.

[30]  I. Weber,et al.  Studies on the role of the S4 substrate binding site of HIV proteinases , 1991, FEBS letters.

[31]  M. Katharine Holloway,et al.  X-Ray Crystal Structure of the HIV Protease Complex with L-700,417, an Inhibitor with Pseudo C2 Symmetry , 1991 .

[32]  A Wlodawer,et al.  Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases. , 1991, Biochemistry.

[33]  J. Louis,et al.  The effect of salt on the Michaelis Menten constant of the HIV‐1 protease correlates with the Hofmeister series , 1991, FEBS letters.

[34]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[35]  A. Wlodawer,et al.  The complexities of AIDS : an assessment of the HIV protease as a therapeutic target , 1991 .

[36]  J. Huff,et al.  HIV protease: a novel chemotherapeutic target for AIDS. , 1991, Journal of medicinal chemistry.

[37]  V. Kostka,et al.  Specificity studies on retroviral proteinase from myeloblastosis-associated virus. , 1991, Biochemistry.

[38]  J. Kay,et al.  Mutating P2 and P1 residues at cleavage junctions in the HIV‐1 pol polyprotein Effects on hydrolysis by HIV‐1 proteinase , 1991, FEBS letters.

[39]  Synthesis of homologous peptides using fragment condensation: analogs of an HIV proteinase substrate. , 2009, International journal of peptide and protein research.

[40]  B. Dunn,et al.  Development of synthetic peptide substrates for the poliovirus 3C proteinase. , 1991, Archives of biochemistry and biophysics.

[41]  M. Hatada,et al.  Novel binding mode of highly potent HIV-proteinase inhibitors incorporating the (R)-hydroxyethylamine isostere. , 1991, Journal of medicinal chemistry.

[42]  A Wlodawer,et al.  Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. , 1991, Biochemistry.

[43]  I. Weber,et al.  Comparative analysis of the sequences and structures of HIV‐1 and HIV‐2 proteases , 1991, Proteins.

[44]  I. Pichová,et al.  Subsite specificity of the proteinase from myeloblastosis associated virus , 1991, FEBS letters.

[45]  T. L. Blundell,et al.  X-ray analyses of peptide–inhibitor complexes define the structural basis of specificity for human and mouse renins , 1992, Nature.

[46]  T. Copeland,et al.  Solid phase synthesis of the proteinase of bovine leukemia virus Comparison of its specificity to that of HIV‐2 proteinase , 1992, FEBS letters.

[47]  P. Darke,et al.  Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted design. , 1992, Journal of Medicinal Chemistry.

[48]  J. A. Martin,et al.  Recent advances in the design of HIV proteinase inhibitors. , 1992, Antiviral research.

[49]  A Wlodawer,et al.  Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates. , 1992, The Journal of biological chemistry.

[50]  K. Brocklehurst,et al.  Variation in the P2-S2 stereochemical selectivity towards the enantiomeric N-acetylphenylalanylglycine 4-nitroanilides among the cysteine proteinases papain, ficin and actinidin. , 1992, The Biochemical journal.

[51]  Narmada Thanki,et al.  Crystal structure of a complex of HIV‐1 protease with a dihydroxyethylene‐containing inhibitor: Comparisons with molecular modeling , 1992, Protein science : a publication of the Protein Society.

[52]  C. Debouck,et al.  Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease. , 1992, Biochemistry.

[53]  B. Dunn,et al.  Substrate specificity and inhibitors of aspartic proteinases. , 1992, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[54]  An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV‐1 proteinase. , 1992, The EMBO journal.

[55]  J. Louis,et al.  Kinetic and modeling studies of S3-S3' subsites of HIV proteinases. , 1992, Biochemistry.

[56]  Intrinsic activity of precursor forms of HIV‐1 proteinase , 1992, FEBS letters.

[57]  A M Hassell,et al.  Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays. , 1992, Biochemistry.

[58]  A Wlodawer,et al.  Mutations that alter the activity of the Rous sarcoma virus protease. , 1992, The Journal of biological chemistry.

[59]  A. Wlodawer,et al.  Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites. , 1992, Biochemistry.

[60]  A. Wlodawer,et al.  Structure-based inhibitors of HIV-1 protease. , 1993, Annual review of biochemistry.

[61]  B. Dunn,et al.  Interactions of substrates and inhibitors with a family of tethered HIV-1 and HIV-2 homo- and heterodimeric proteinases. , 1994, The Journal of biological chemistry.

[62]  A Wlodawer,et al.  Energy calculations and analysis of HIV-1 protease-inhibitor crystal structures. , 1994, Protein engineering.